Surgical Microscopes Market Size, Share And Trends Analysis Report 2022-2030

The global surgical microscopes market size is expected to reach USD 2.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 11.37% from 2022 to 2030. With the advent of surgical microscopes, it became easier for surgeons to perform such procedures more accurately in less time. In addition, the introduction of technologically advanced products is driving the demand for surgical microscopes as they are more precise, offer better illumination sources, and provide options for customization and technology integration based on the complexity of the procedures.

Emerging technologies such as wide-angle illumination, Red Reflex illumination, automation and augmented reality microscopy are expected to boost the market growth. International players like Carl Zeiss Meditec AG and Leica Microsystems are contributing to the market by providing highly advanced, automated, and robotic surgical microscopes for more precision.

In response to the COVID-19 pandemic, hospitals decided to suspend all the elective and non-urgent surgeries, which has negatively impacted the market. However, with the ease of restrictions, treatments are resuming in many countries, including developing nations. Also, many companies, such as Alcon and Carl Zeiss, have resumed their business operations with the given government guidelines to deliver their orders.

Surgical Microscopes Market

Surgical Microscopes Market Report Highlights

• On casters was the largest type segment in 2021 due to the high portability & flexibility and low maintenance requirements of these tools. Moreover, the segment is expected to register the fastest growth over the forecast period due to the high use of casters microscope in various surgical fields

• The ophthalmology application segment accounted for the maximum revenue share in 2021. However, the ENT surgery segment is expected to register the fastest CAGR from 2022 to 2030. According to data published by The Children’s Hospital of Philadelphia, tympanostomy tube insertion surgery, also known as ear tube surgery, is the most commonly performed surgery in children in the U.S. More than 4,000 ear tube surgeries are performed each year at the hospital. Thus, an increasing number of ENT procedures is likely to favor segment growth

• Carl Zeiss Meditec AG and Leica Microsystems (Danaher Corporation) are the major players in the surgical microscopes market. Launch of new products, acquisitions, and geographic expansion are some of the strategies being adopted by key players in the market. In February 2019, Danaher Corporation acquired the Biopharma business of GE Healthcare, which also includes microscopy products the company

• Manufacturers such as Alcon, Nikon, and Carl Zeiss reported the decreases in the revenue in the second quarter of the year 2020 due to the impact of the COVID-19 pandemic which affected the supply chain of most of the companies. Currently, most of the companies have resumed their business and are delivering orders within the given guidelines pertaining to the COVID-19 pandemic

Life Science Microscopes Industry Size was valued at USD 3.36 Billion in 2021 and is projected to expand at a CAGR of 8.9% during 2022 to 2030.

Surgical Microscopes Market Segmentation

Grand View Research has segmented the global surgical microscopes market report based on  type, application, end use, and region:

Surgical Microscopes Market - Type Outlook (Revenue, USD Million, 2017 - 2030)

• On Casters

• Wall Mounted

• Tabletop

• Ceiling Mounted

Surgical Microscopes Market - Application Outlook (Revenue, USD Million, 2017 - 2030)

• Neurosurgery and Spine Surgery

• ENT Surgery

• Dentistry

• Gynecology

• Urology

• Ophthalmology

• Plastic & Reconstructive Surgeries

• Other Surgeries

Surgical Microscopes Market - End Use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospital

• Physician Clinics and Other Settings

Surgical Microscopes Market - Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa (MEA)

List of Key Players in Surgical Microscopes Market

• Carl Zeiss Meditec AG

• Leica Microsystems

• Olympus Corp.

• Hagg-Streit Surgical GmbH

• Synaptive Medical

• Alcon, Inc.

• Topcon Corp.

• Takagi Seiko Co., Ltd.

• ARI Medical Technology Co., Ltd.

• Chammed Co., Ltd.

• Seiler Instrument, Inc.

Request free sample copy of Life Science Microscopes Industry Data Book @ https://www.grandviewresearch.com/sector-report/life-science-microscopes-industry-data-book/request/rs1

Solar Energy Generation Industry ESG Thematic Report, 2022

Sustainability Assessment, Policies & Regulations, ESG Issues, Infrastructure Developments, Company Profiles, Benchmarking, SWOT, Company ESG Disclosure Scores

The average ESG score for the solar energy generation industry is between 55% and 65%. Our proprietary ESG scoring framework analyzed 65 parameters across the environment, social, and corporate governance, as represented in the methodology section of this document. E.ON SE, Exelon Corporation, and five other market leaders were part of our research. Four of the market leaders ranked above average industry scores. However, one company needs to focus more on ESG reporting and transparency, as it scored well below the industry average. The majority of sustainability-related disclosures are centered on governance metrics, followed by environmental and social disclosures. 

E.ON SE leads the sector in terms of ESG disclosure, followed by Exelon Corporation and Equinor ASA.

For More Details: https://astra.grandviewresearch.com/solar-energy-generation-industry-esg-outlook

Environmental insights

Solar energy is one of the most impactful renewable energy sources that have significant potential in driving the energy transition. For example, solar panels can be used to generate clean power at home and reduce the cost of electricity in the long term. Solar panels are also a boon to the environment, as they reduce pollution. A well-built solar system within the premises can also help charge electric cars. Greater use of solar energy can, therefore, lower the need for nonrenewable fossil fuel sources, such as coal, natural gas, and so on. The use of solar power will have an immediate, measurable impact on the environment and provide a good Return on Investment (ROI).

The Exelon Corporation ranks first among the top five companies that have avoided around 78 million tons of GHG emissions through the use of zero-carbon nuclear power. 

Overseeing the climate risk strategy is an imperative aspect that needs to be institutionalized. The climate strategy of Exelon Corporation is overseen by a Senior Vice President of Corporate Strategy and Chief Innovation and Sustainability Officer, while Equinor ASA's strategy is overseen by the Safety, Sustainability, and Ethics Committee (SSEC) of its board of directors. Furthermore, E.ON SE is one of the top three companies in the environmental sector, with 86% of sites certified according to ISO 14001.

Social insights

Solar energy generation companies have emphasized various social aspects such as turnover rate, health & safety, diversity, enterprise & employee/customer communications through surveys, and human rights alignment. These areas are essentially the foundation of a company’s social pillar. Our research found that ESG disclosure around social pillars has not been significant, and it has scope for improvement. With respect to social disclosure, E.ON SE leads the way, followed by Duke Energy Corporation and Exelon Corporation.

Among the top three companies, E. ON SE had the lowest turnover rate, which indicates the company has managed its human capital well with high employee satisfaction. All top three companies emphasized safety metrics, which is evident from the health and safety measures that are institutionalized within their operations. In addition to the safety measures, the majority of the companies within the sector also provide employees additional health benefits, including mental health support, programs that support emotional & social health, life coaching, and many other benefits. It was noticed that only one company had 87% of its business units certified to ISO 45001 while the other two did not have safety certifications.

Our assessment showed that all major companies within the sector have conducted comprehensive employee and customer satisfaction surveys.

Governance insights

According to our research, the average industry governance score is 71%, which is the highest among all the ESG pillars. The governance pillar included information on female board members, independent directors, compensation linked to ESG parameters, and clawback policy, among others. The industry leaders scored well above 75% in the corporate governance pillar, with Exelon Corporation scoring the highest, followed by E.ON SE and Duke Energy Corporation.

The corporate governance structure becomes robust with more independent representation on the board. Our research showed that 100% of E.ON SE's directors were Independent directors, while Exelon Corporation had the lowest percentage of independent directors. An inclusive board structure demonstrates the company's commitment to diversity as well. 

Exelon Corporation had the highest percentage of females on its board at 33.33% followed by the others.

Country-level insights

The increased popularity of solar energy is quite evident from the rising number of solar energy producers across countries. The top solar power nations, such as China, are heavily reliant on clean energy with their 2030 net-zero target. The increase in clean energy investment has led to new economic and employment opportunities. Incentive policies for solar projects were introduced in the year 2020 across various countries. Few countries have also introduced incentive plans and have defined policies for solar power, which is explained in detail within the report.

Sembcorp Industries Ltd, a Singaporean company, acquired a 98% stake in GCN Capital Partners Infrastructure Fund III and its subsidiary for RMB 3.3 billion (USD 505,560,000). 

Request for Free Demo: https://astra.grandviewresearch.com/solar-energy-generation-industry-esg-outlook/request/rs1

Lubricant Industry ESG Thematic Report, 2022

Sustainability Assessment, Policies & Regulations, ESG Issues, Infrastructure Developments, Company Profiles, Benchmarking, SWOT, Company ESG Disclosure Scores

The average ESG disclosure score for the lubricant market is between 55% and 65%. Our proprietary Environment, Social, and Corporate Governance (ESG) scoring framework analyzed 65 parameters across ESG, as represented in the methodology section of this document. Royal Dutch Shell, British Petroleum (BP), Chevron, and 11 more market leaders were part of our research. Three out of five companies we researched scored above the average industry score. However, four market leaders need to focus more on ESG reporting and transparency as they scored well below 50%.

For More Details: https://astra.grandviewresearch.com/lubricant-industry-esg-outlook

Environmental insights

Lubricant comprises less than 10% additives and 90% base oil (like petroleum fractions, called mineral oils). In rotating machinery, lubrication is crucial for efficiency and durability. Lubrication reduces friction between machine parts and enables them to move smoothly in a given direction. There is a negative impact of lubricant on the environment, as it causes serious contamination of soils and groundwater, as well as accumulates in plants and animal tissues. There are various measures or technologies used by companies globally for the sustainability of lubricants. One of the main alternatives to petroleum-based lubricants is bio-based lubricants, which can help reduce environmental impact and create green companies. 

Social insights

Broadly, social metrics represent an assessment of risks that a company might experience from human capital and community, both. The parameters that are considered in this category include not only the employee turnover rate but also health & safety parameters, including injury rates, OHSAS certifications, employee engagement programs, training, and community development, among others. Among the companies within the sector, Idemitsu Kosan ranks highest on the social pillar, with a score of around 70%. The company has institutionalized robust human rights monitoring mechanisms not only within its own operations but also across the operations of its entire supply chain.

Governance insights

The governance aspect within the purview of ESG assessment is one of the most important foundation stones of a company, which includes various metrics, including business ethics, board structure, financial transparency, anti-corruption, and insider trading, among others. As per Grand View Research’s ESG scoring model, Chevron ranks the highest in corporate governance among its peers operating within the lubricants sector. The company has the highest number of independent directors (over 90% of the board comprises independent directors), which enhances corporate credibility and governance standards in the eyes of investors and consumers. Chevron has also institutionalized one of the best-in-class ethics platforms that manage any form of misconduct within the company.

Request for Free Demo: https://astra.grandviewresearch.com/lubricant-industry-esg-outlook/request/rs1

Electric Passenger Cars Industry ESG Thematic Report, 2022

Sustainability Assessment, Policies & Regulations, ESG Issues, Infrastructure Developments, Company Profiles, Benchmarking, SWOT, Company ESG Disclosure Scores

The average ESG disclosure score for the electric passenger cars industry is between 60% and 70%. Our proprietary ESG scoring framework analyzed 65 parameters across the environment, social, and corporate governance, as represented in the methodology section of this document. General Motors (GM), Mitsubishi Motor Corporation (MMC), and seven other market leaders were part of our research. Seven out of nine companies we researched scored above the average industry score. However, two market leaders need to focus more on ESG reporting and transparency as they scored well below 50%.

For More Details: https://astra.grandviewresearch.com/electric-passenger-cars-industry-esg-outlook

Environmental insights

In recent years, Electric Vehicles (EVs) have become more popular, which has been good news for the environment. Switching to EVs helps in avoiding the exhaustion of finite resources and also provides another way to reduce carbon footprint because these vehicles have no tailpipe emissions, which is a direct contributor to global warming. Companies in the EV market have institutionalized stringent targets to fight climate change and global warming. Most of the players like Nissan motors have programs for managing waste and reducing water consumption through the 3R (Reduce, Reuse, Recycle) and Circular Economy models. 

Social insights

Social metrics assess the risk to a company from community and human capital, which include employees & stakeholders and their relationship with them. Employees’ and safety parameters covering OHSAS certifications, and injury rates, alongside employee training & development, employee engagement programs, privacy, supply chain transparency, and human rights are majorly included in this category. With a social disclosure score of 67%, Toyota Motor Corporation ranks the highest. Most of the companies, including the top three, have separate supplier CSR guidelines or human rights policies aligned with the United Nations Guiding Principles on Business and Human rights, except Volkswagen AG, which lacks a separate supplier code of conduct on human rights or any such supply chain policy.

Governance insights

Corporate governance practices are core to an organization as understanding opportunities and risks in governance is critical for decision-making. Governance is one of ESG’s core components and assesses the purpose of a corporation, the role of directors, the make-up of directors, gender diversity, equity, and compensation of boards. Independent directors on the board play a crucial role in improving governance standards and corporate credibility. In 2020, GM had the highest representation of independent directors on board with over 90% independent directors on its board. Furthermore, in terms of diversity in the board, GM had the highest percentage of females on board, with more than 50% female members on board. 

Request for Free Demo: https://astra.grandviewresearch.com/electric-passenger-cars-industry-esg-outlook/request/rs1

Point-Of-Sale (POS) Terminal Industry ESG Thematic Report, 2022

Point-Of-Sale (POS) Terminal Industry ESG Sustainability Assessment, Policies & Regulations, ESG Issues, Infrastructure Developments, Company Profiles, Benchmarking, SWOT, Company ESG Disclosure Scores

The average ESG disclosure score for the point-of-sale terminal Industry is between 60% and 70%. Our proprietary Environment, Social, and Corporate Governance (ESG) scoring framework analyzed 65 parameters across ESG, as represented in the methodology section of this document. Hewlett Packard Inc., Toshiba Corporation, Panasonic Corporation, and seven more market leaders were part of our research. Six out of 10 companies we researched scored above the average industry score. However, three market leaders need to focus more on ESG reporting and transparency, as they scored well below 50%. Our research shows that most of the sustainability-related revelations have been made around ecological measurements, which stand at almost 75%, followed by governance and social with a score of ∼ 60% and ∼ 50%, respectively. Hewlett-Packard, Inc.

For More Details: https://astra.grandviewresearch.com/point-of-sale-terminal-industry-esg-outlook

Environmental insights

During the COVID-19 pandemic, the global transition from the coin- and paper-based payments to digital transactions implies that the quantity of Point-of-Sale (POS) terminals is rapidly growing. However, this development is accompanied by liability; not exclusively to consider the effect the increased number of gadgets has on various factors like financial incorporation, additionally with the ecological impact of the assembling process of payment terminals, their transportation, use, support, and end-of-life handling. Some of the significant sustainability challenges faced by the industry are generation & disposal of e-waste during the end-of-life of POS equipment; large-scale use of paper in the form of printed receipts, resulting in waste generation; and the supply chain disruptions arising from semiconductor shortages, which have led to the adoption of various methods such as reducing top margin, on-demand printing, receipt compression, and greener manufacturing, such as halogen-free cases & recyclable packaging.

Players in the POS terminal industry are continuously attempting to increase the number of produced units and strengthen their presence across the globe by adopting eco-friendly operations and defining relevant targets to track their progress. For instance, Panasonic Corporation has aligned to the Green Plan 2021 to mitigate both product and production activities through evaluation of water risks across all regions. Moreover, the company has also reduced the emission of waste by boosting yield in its production process and by increasing the recycling rate of waste materials by strictly adhering to Waste Sorting Practices in the production processes

Social insights

Predominantly, social metrics consist of an assessment that covers both the parameters–human capital and community. The variables that are accounted for in this classification are employee turnover rate as well as their wellbeing & security, including injury rates, and OHSAS certificates, alongside government assistance provided to both workers & clients. Among the companies within the sector, Toshiba Corporation ranks highest on the social pillars with a score of around 90%. It has standardized robust human rights checking components not only within its own operations but also across the supply chain. It also considers the health and safety of its employees as a priority factor.

Moreover, Samsung Electronics is an exception, which has one of the highest employee turnover rates (18.10%) despite having comprehensive healthcare plans for employees. The firm also provides robust H&S training and health insurance to its employees with many training programs, such as leadership training, to strengthen specialization at work, which resulted in the lowest injury rate among its peers. Furthermore, it also helps employees with external training opportunities such as MBA, academic training, job expert courses, regional expert classes, and AI expert courses.

Governance insights

The Governance aspect within ESG evaluation is one of the principal foundation stones of an association, which integrates various estimations, including business ethics, board structure, monetary issues, payoff, succession planning, and statutory audits, among others. As per Grand View Research’s ESG scoring model, HP ranks the highest in corporate governance among its peers operating in the point-of-sale terminal market. The organization has the highest number of independent directors (more than 91% of the board includes autonomous chiefs or independent directors), which enhances corporate responsibility and administrative principles in accordance with investors and consumers.  HP has a designated Chief Information Security Officer (CISO) who monitors privacy-related issues. It also has the highest percentage of female members on its board, which is above 45%. This depicts a positive diversity initiative, and the incorporation of planned annual incentives for its top executives, linked to the sustainability performance, helps boost accountability for sustainability performance. Due to the institutionalization of a robust business continuity plan consisting of emergency responses along with disaster prevention & mitigation responses, Panasonic Corporation ranked second in the governance metrics.

Request for Free Demo: https://astra.grandviewresearch.com/point-of-sale-terminal-industry-esg-outlook/request/rs1

Antiviral Drugs Market Analysis, Competitive Landscape, Current and Future Trends to 2028

Antiviral Drugs Industry Overview

The global antiviral drugs market size to be valued at USD 60.0 billion by 2028 and is expected to grow at a compound annual growth rate (CAGR) of (-0.6%) during the forecast period. The introduction of the generic version of antiviral medicines and growing awareness about the availability of various vaccines for viral infections is affecting the growth during the forecast period.

However, the increasing prevalence of viral infections such as HIV, Herpes, Influenza, and others are expected to increase the demand for antiviral medicines over the forecast period. For instance, according to UNAIDS, in 2020, more than 37 million individuals were living with HIV across the globe. Out of these, approximately 1.5 million new people acquired HIV infection in 2020. Overall, the COVID-19 pandemic has significantly increased market growth in 2020 whereas, a negative impact of the pandemic has been observed for other applications of antiviral drugs.

The increasing incidence of viral infection across the globe is a major factor driving the demand for antiviral drugs over the forecast period. According to WHO, globally, an estimated 325 million people are living with hepatitis infection and out of these, around 71 million have chronic hepatitis C virus infection. Moreover, the U.S. Department of Health and Human Services has estimated that 2.4 million people are living with hepatitis C in the United States and around 850,000 individuals in the country have hepatitis B infection. An increasing base of patients is anticipated to increase the demand for antiviral drugs globally.

Gather more insights about the market drivers, restrains and growth of the Global Antiviral Drugs Market

Increasing approval and expected commercialization of novel medicines for viral infections are anticipated to drive market growth. For instance, in November 2020, the U.S. FDA has approved a supplemental New Drug Application for Roche’s Xofluza for the treatment of influenza in patients 12 years of age and older. Moreover, the major players in the market have launched many novel medicines in 2 to 3 years for the treatment of viral infections. For instance, Gilead Sciences, Inc. has launched Biktarvy, Symtuza, and Veklury for the treatment of viral infections. Furthermore, GlaxoSmithKline plc. has launched Dovato, Cabenuva, and Juluca for the treatment of diseases caused by the virus. An increase in the introduction of novel products in the market will drive growth over the next 2 to 3 years.

The outbreak of the COVID-19 pandemic has significantly increased the demand for antiviral medicines globally. The treatment of novel coronavirus has increased the demand for broad-spectrum antiviral drugs to manage the disease. Remdesivir, favipiravir, oseltamivir, and other combination medicines are highly prescribed for the treatment of COVID-19. Moreover, governments are increasing funding to pharmaceutical companies to develop novel therapeutics against COVID-19. For instance, in June 2021, the U.S. government has announced an investment of more than USD 3 billion to fasten the discovery, development, and manufacturing of antiviral medicines for COVID-19 treatment. The rising incidence of disease coupled with increasing R&D will increase the demand for antiviral drugs in the next 2 to 3 years.

Increasing collaborations for the development and manufacturing of antiviral drugs are expected to result in the development of a high number of novel drugs in the coming years. The key players in the market are collaborating for the R&D of new therapies to reduce the burden of viral infection treatment. For instance, in 2020, Gilead Sciences, Inc. has signed licensing agreement with pharmaceutical manufacturers such as Cipla Ltd., Hetero Labs Ltd., Dr. Reddy's Laboratories Ltd., Mylan, and others to expand the supply of remdesivir.

Browse through Grand View Research's Pharmaceuticals Industry Research Reports.

• Immunotherapy Drugs Market: The global immunotherapy drugs market size was valued at USD 110.55 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.92% from 2022 to 2030. The market is primarily driven by the rising incidence of chronic diseases globally.

• Topical Drugs Market: The global topical drugs market size was valued at USD 97.42 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 10.1% from 2022 to 2030. The industry growth is primarily driven by the rising incidence of skin disorders and diabetes. According to the British Journal of Dermatology, skin diseases affect almost one-third of the global population.

Antiviral Drugs Market Segmentation

Grand View Research has segmented the global antiviral drugs market on the basis of drug class, type, application, and region:

Antiviral Drug Class Outlook (Revenue, USD Million, 2017 - 2028)

• DNA Polymerase Inhibitors

• Reverse Transcriptase Inhibitors

• Protease Inhibitors

• Neuraminidase Inhibitors

• Others

Antiviral Drugs Type Outlook (Revenue, USD Million, 2017 - 2028)

• Branded

• Generics

Antiviral Drugs Application Outlook (Revenue, USD Million, 2017 - 2028)

• HIV

• Hepatitis

• Herpes

• Influenza

• Others

Antiviral Drugs Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Key Companies profiled:

Some prominent players in the Global Antiviral Drugs Market include

• F. Hoffmann-La Roche Ltd.

• GlaxoSmithKline plc

• AbbVie

• Merck & Co., Inc.

• Johnson & Johnson Services, Inc.

• Bristol-Myers Squibb Company

• Cipla Inc.

• Aurobindo Pharma

• Dr. Reddy’s Laboratories Ltd.

Order a free sample PDF of the Antiviral Drugs Market Intelligence Study, published by Grand View Research. 

Augmented Reality & Virtual Reality In Healthcare Market Key Global Players & Recent Developments to 2028

Augmented Reality & Virtual Reality In Healthcare Industry Overview

The global Augmented Reality & Virtual Reality in healthcare market size was valued at USD 2.0 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 27.2% from 2021 to 2028. 

Technological advancements and digitalization in healthcare, favorable government initiatives, rising healthcare expenditure, growing usage in surgical procedures, and medical training are some of the fundamental factors anticipated to boost the growth and adoption of the augmented reality (AR) and virtual reality (VR) technologies in the healthcare industry. These technologies have wide applications in healthcare including surgeries, diagnostics, rehabilitation, training, and education.

Augmented and virtual reality techniques are being increasingly adopted in surgeries and diagnostics. Systems such as touch surgery use virtual reality to provide a view of the patient’s anatomy and physiology, thereby providing opportunities for surgeons in the operating room, This, in turn, is expected to augment the growth of the market for augmented reality and virtual reality in healthcare. The growing adoption of Augmented Reality (AR) and Virtual Reality (VR) technologies in medical surgeries to optimize surgical procedures and increase the efficiency of treatment is one of the key factors driving market growth over the past few years. For instance, in December 2019, Augmedics launched the Xvision Spine AR guidance system for spine surgeries in the U.S. This solution allows the surgeon to view the 3D spinal anatomy of the patient during the surgery. Augmedics also received the U.S. FDA approval for Xvision in December 2019. Moreover, the increasing practice of storing medical images and patient data on the AR/VR platform helps in reducing requirements for expensive screens and unnecessary staff.

Gather more insights about the market drivers, restrains and growth of the Global Augmented Reality & Virtual Reality In Healthcare Market

Additionally, AR is being widely adopted for education and training purposes for medical personnel. Since AR-based learning modules provide anatomical visualization and simulation it gives the medical personnel a more wholesome complete learning experience. Moreover, these learning modules are even being used to train patients and help them understand the treatment flow and care management better. AR-based image visualization assists the surgeons and enhancing their accuracy and precision during complex surgeries. For instance, in February 2019 Philips Healthcare collaborated with Azurion and Microsoft to develop a mixed reality concept to provide a 3D holographic AR environment derived from multiple image modalities to assist surgeons.

During the outbreak of the COVID-19 pandemic, AR & VR in healthcare was influenced positively owing to the technological advancements in this space. For instance, in April 2020 XRHealth extended its application by raising USD 7 million to expand its telehealth platform. Similarly, Imperial College and St. Mary’s Hospital in London are using augmented reality glasses to visualize 3D imaging of blood vessels during reconstructive surgeries. Augmented reality and virtual reality in healthcare help in efficiently managing the treatment schedules, treatment delivery, and plans, and thereby it is anticipated to exponentially grow during the pandemic. Additionally, the decreasing costs in healthcare, rapid digitalization of healthcare, and improved delivery of effective health services are expected to drive growth. AR and VR in healthcare are gaining momentum due to widespread adoption in telemedicine, medical training & education, patient care management, medical marketing during the COVID-19 pandemic.

Furthermore, mergers and acquisitions, product development and launches, partnerships, and collaborative agreements are some of the crucial initiatives being undertaken by key players, which are expected to propel market growth. For instance, in January 2021 Hologic Inc acquired Biotheranostics, a molecular diagnostics company for USD 230 million. Through this acquisition, Hologic Inc and Biotheranostics will combine their capabilities and utilize their expertise in oncology diagnostics and advanced woman health diagnostics.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• Oncology Information Systems Market: The global oncology information systems market was valued at USD 2.4 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030. Monumental growth of healthcare IT, the increasing global prevalence of cancer, increasing expenditure in development around treatment & solutions for cancer care, and increasing adoption of OIS solutions by healthcare facilities is some of the key factors anticipated to drive the growth of the market.

• Real World Evidence Solutions Market: The global real world evidence solutions market size was valued at USD 39.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.1% from 2022 to 2030. Support from regulatory bodies for using real world evidence (RWE) solutions and an increase in R&D spending are anticipated to boost the market growth. 

Augmented Reality & Virtual Reality In Healthcare Market Segmentation

Grand View Research has segmented the global augmented reality & virtual reality in healthcare market on the basis of component, technology, and region:

AR & VR In Healthcare Component Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware

• Software

• Service

AR & VR In Healthcare Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Augmented Reality

• Virtual Reality

AR & VR In Healthcare Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

Key Companies profiled:

Some prominent players in the Global Augmented Reality & Virtual Reality In Healthcare Market include

• CAE

• GE Healthcare

• Koninklijke Philips N.V.

• Intuitive Surgical

• Siemens Ltd

• Eon Reality, Inc

• Layar

• Bioflight VR

• WorldViz

• TheraSim Inc

• Mindmaze

Order a free sample PDF of the Augmented Reality & Virtual Reality In Healthcare Market Intelligence Study, published by Grand View Research.